+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Viral Vector"

From
From
From
From
From
From
Cell Cryopreservation Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Cell Cryopreservation Market - Forecasts from 2024 to 2029

  • Report
  • January 2024
  • 146 Pages
  • Global
From
CRISPR Market - Forecasts from 2021 to 2026 - Product Thumbnail Image

CRISPR Market - Forecasts from 2021 to 2026

  • Report
  • July 2021
  • 112 Pages
  • Global
From
From
From
Metagenomics Sequencing Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Metagenomics Sequencing Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Loading Indicator

The Viral Vector market is a subset of the biotechnology industry that focuses on the development and production of viral vectors for gene therapy. Viral vectors are modified viruses that are used to deliver genetic material into cells, allowing for the expression of a desired gene. This technology has been used to treat a variety of diseases, including cancer, genetic disorders, and infectious diseases. Viral vectors are produced through a variety of methods, including recombinant DNA technology, synthetic biology, and cell-based systems. The production of viral vectors requires specialized equipment and expertise, making it a highly specialized field. The Viral Vector market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Novartis, Merck, Pfizer, AstraZeneca, and Sanofi. Additionally, there are a number of smaller companies that specialize in the production of viral vectors, such as Viralgen, Oxford BioMedica, and Vigene Biosciences. Show Less Read more